XML 49 R28.htm IDEA: XBRL DOCUMENT v3.22.4
Acquisitions (Tables)
12 Months Ended
Dec. 31, 2022
Business Acquisition [Line Items]  
Summary of Supplemental Pro Forma Information (Unaudited)

Net revenue and loss from operations for the year ended December 31, 2022 was $12.9 million and $0.3 million, respectively, since the Acquisition Date. The following unaudited pro-forma summary presents consolidated information of the Company as if the acquisition had occurred on January 1, 2021 (in thousands):

Supplemental Pro Forma Information (unaudited)

 

 

December 31,

 

 

 

2022

 

 

2021

 

Net revenue

 

$

109,933

 

 

$

98,278

 

Net loss

 

 

(86,967

)

 

 

(80,806

)

 

 

 

 

 

 

 

 

 

Net loss per share - basic and diluted

 

$

(0.34

)

 

$

(0.32

)

Schedule of Consideration Paid for IPR&D The Company purchased all of the outstanding capital stock of QrumPharma for consideration consisting of cash and shares of the Company’s common stock, subject to adjustment for cash on hand, unpaid indebtedness, unpaid transaction expenses, and net working capital as follows (in thousands):

Consideration

 

 

 

 

Cash consideration

 

$

3,574

 

Stock consideration (3,067,179 shares at $3.01 per share)

 

 

9,250

 

Transaction costs

 

 

531

 

Repayment of debt

 

 

11

 

Liabilities assumed

 

 

22

 

Cash acquired

 

 

(155

)

Total consideration paid for IPR&D

 

$

13,233

 

 

V-Go  
Business Acquisition [Line Items]  
Schedule of Preliminary Purchase Consideration

The total preliminary purchase consideration for V-Go was as follows (in thousands):

Fair value of consideration:

 

Amount

 

Cash consideration

 

$

15,341

 

Fair value of contingent consideration

 

 

610

 

Total

 

$

15,951

 

Schedule of Preliminary Amounts of Identifiable Assets Acquired and Liabilities Assumed

The information below reflects the preliminary amounts of identifiable assets acquired and liabilities assumed as of the Acquisition Date (in thousands):

 

 

Amount

 

Assets:

 

 

 

 

Inventory

 

$

11,152

 

Property and equipment

 

 

2,921

 

Goodwill

 

 

2,428

 

Intangible asset - Developed technology

 

 

1,200

 

Operating lease right-of-use assets

 

 

1,812

 

Total assets

 

 

19,513

 

Liabilities:

 

 

 

 

Liabilities assumed

 

 

1,750

 

Operating lease liability

 

 

1,812

 

Total liabilities

 

 

3,562

 

Net assets acquired

 

$

15,951